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Nowadays – we have just had the 2012 Olympic and Paralympic Games in London – 
sports seems to have an increasing impact on society. This impact is of course 
ambivalent, i.e. sport can promote health but sport, especially high performance 
sports, can quite often be nothing but a health ruining activity. At the same time we 
can observe that progress in the field of genomics is enormous. Discoveries in this 
area are a source of inspiration for researchers in various fields to apply the 
findings not only to the field of plants and animals genomics, but also to human 
beings. It seems as if sports serves as the ideal playground (maybe laboratory would 
be the better metaphor) for genomics in order to test outcomes in real life. The 
possibilities range from apparently ethically tolerable applications (preventive genetic 
testing), to ethically unacceptable measures (gene doping). But it is necessary to avoid 
black and white thinking and to identify the ethical issues in genomics when applied 
to the field of sports, and not to let one’s opinion be influenced by a superficial 
perception of the problems. With this special issue we want to provide material for 
future discourse and future policy making (including guidelines and 
recommendations) in this area. Thus the focus of this special issue is clearly on 
questions around genetic testing/screening, especially in prevention, particularly 
genetic testing as a diagnostic tool to identify hereditary health risks that could have 
severe consequences if undetected in athletes. However, preventive/diagnostic 
applications are sometimes hard to distinguish from enhancing measures, especially 
when we are talking about sports. Although the focus is not on gene doping, van 
Hilvoorde and Camporesi and McNamee address this subject in order to provide the 
reader with a complete picture of possible use and misuse. 
 
The first paper, by Ivo van Hilvoorde, paves the way into the topic of sports and 
genomics. He provides a first sketch of possible applications of genomics in the field 
of physical activity by focusing on a) the prevention of sports-related genetic risks, b) 
on genetic screening in order to create an ‘efficient’ selection process in elite sport, 
and c) on utopian and dystopian scenarios around genetic enhancement. Although the 
application of DNA testing as a preventive tool seems morally more acceptable than 
the selection of talents with the help of genetic screenings, van Hilvoorde reflects 
upon the ethical controversies in both applications. For example, mandatory DNA 
testing in high-performance athletes (e.g. tests for boxers, in order to reduce their risks 
for Parkinson’s or Alzheimer's disease) is ethically ambivalent, even if it is applied 
for a preventive reason. As van Hilvoorde informs us, on the one hand knowledge 
about our genetic makeup can contribute to a process of empowerment (the 
enhancement of the athletes autonomy), but on the other hand this information can 
lead to a restriction of our choices (athletes, especially children, might feel 
preassigned to a certain sports discipline, hence limited in their sporting future by 
knowledge about their genetic makeup). Another example of ambivalence is 
presented when van Hilvoorde touches upon the question of gene doping, especially 
when he reflects on the problem of defining the border between therapy and 
enhancement. 
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Let’s buy a test online and soon you will know what kind of sport star you could 
become. Sabine Rudnik-Schöneborn destroys such fantasies at the very beginning of 
her paper. She provides results of research studies that tried to confirm the promises 
of, for example,  commercially available tests for ACTN3 (=α-actinin 3) – such tests 
are said to forecast whether a person has a higher potential in sprint and strength 
training or endurance sports – however, the promising results could not be reproduced 
in scientifically sound settings (such as a larger test population). Rudnik-
Schöneborn’s sobering conclusion is that although many genes are supposed to have 
an influence on sports performance, the current state of knowledge in this field is still 
in its infancy. However, she states that there are other (rare) genes which are highly 
predictive of certain disorders, where competitive sports should be avoided, to avoid 
sudden cardiac death (see also the Löllgen/Löllgen paper in this issue). While the 
screening of the whole population seems to be impossible, according to Rudnik-
Schöneborn cascade screening of relatives in families with known mutations could be 
a clever strategy for detection. 
 
What's the difference between a scenario where an athlete asks for a gene transfer in 
order to increase their pain tolerance and a scenario where a (regular) patient asks for 
the same? Camporesi and McNamee explore the differences and similarities of those 
two scenarios.  They also reflect upon the therapy/enhancement issue introduced by 
van Hilvoorde. The authors show that the boundaries between these two – therapy and 
enhancement – are easily blurred. Interestingly, the authors take Dr Gregory House 
from the TV series House MD as an example for a regular patient having a gene 
transfer to solve his pain issues. In the second scenario they take endurance athletes 
who are seeking a VEGF (Vascular Endothelial Growth Factor) gene transfer to better 
cope with pain and who could therefore perform better than other athletes with a 
normal pain sensitivity. The authors analyse these two scenarios with the help of two 
ethical frameworks: firstly, the ethics of translational research (referring to the gap 
between cutting-edge research and its clinical application), and secondly, the ethics of 
sports enhancement. While the authors conclude that it is acceptable for a regular 
patient to have gene transfer, they provide sound ethical arguments for not allowing 
the same in the case of a performance athlete. 
 
As we have seen in the paper by Rudnik-Schöneborn it might be sensible to 
recommend a genetic test to athletes to avoid, for example, sudden cardiac death. 
Herbert Löllgen and Ruth  Löllgen  elaborate in depth the empirical evidence, 
possibilities and recommendations in this area. They provide up-to-date scientific data 
for various inherited cardiological diseases. Nevertheless, the authors remind us of the 
limited nature of genetic testing, i.e. that we are dealing with probabilistic scores only 
rather than quantitative results. However, they state that it is essential that 
professionals from various disciplines should co-operate in order to create the best 
results for the athlete/ patient. 
 
Besides the scientific evidence and the ethical reflection on the issues around genetics 
and sports presented by the authors mentioned above, we are honoured that this 
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special issue includes an interview with an internationally renowned athlete and 
member of one of the most powerful sports associations, the International Olympic 
Committee (IOC),  Claudia Bokel. Mrs Bokel, an Olympic medal-winning fencer, 
provides us with comments on a number of issues ranging from the development of 
the Paralympic Games and its relation to technological doping, through genetic testing 
for performance athletes, to responsibilities of various stakeholders in regard to the 
athlete’s health. 
 
Finally, I would like to thank . Hub Zwart for the invitation and the honour to serve as 
guest editor for this special issue of Genomics, Society and Policy. I would like to 
thank all the authors and Claudia Bokel for their thoughtful contributions to a 
discourse on a speedily evolving field, and all reviewers for their helpful comments. I 
would also like to express my heartfelt thanks and appreciation for Claire Packman, 
who did an outstanding job as managing editor. 
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University of Leipzig  
 
